Daniela Fliegner
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Cardiovascular Effects of Exercise
- Genetics top 10%
- Estrogen and related hormone effects
Papers in
-
- Cardiac Fibrosis and Remodeling 11
- Cardiovascular Effects of Exercise 1
- Genetics 6
- Estrogen and related hormone effects 6
- Co-authors
- Vera Regitz‐Zagrosek (14 shared papers)Georgios Kararigas (9 shared papers)Elke Dworatzek (7 shared papers)Carola Schubert (6 shared papers)Jan-Ακε Gustafsson (4 shared papers)Adam Penkalla (3 shared papers)Shokoufeh Mahmoodzadeh (4 shared papers)Hugo Sanchez‐Ruderisch (4 shared papers)
- Journals
- Cardiovascular Research (4 papers)Handbook of experimental pharmacology (2 papers)PLoS ONE (2 papers)Journal of Cellular and Molecular Medicine (1 paper)Journal of Molecular Medicine (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Daniela Fliegner
21 papers receiving 1k citations
Peers
Comparison fields: 5 of 70
- Cardiology and Cardiovascular Medicine 483
- Genetics 190
- Molecular Biology 258
- Complementary and alternative medicine 35
- Cancer Research 48
Countries citing papers authored by Daniela Fliegner
This map shows the geographic impact of Daniela Fliegner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Fliegner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Fliegner more than expected).
Fields of papers citing papers by Daniela Fliegner
This network shows the impact of papers produced by Daniela Fliegner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Fliegner. The network helps show where Daniela Fliegner may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Fliegner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 218 | |
| 2 | 2008 | 127 | |
| 3 | 2018 | 95 | |
| 4 | 2013 | 89 | |
| 5 | 2016 | 72 | |
| 6 | 2014 | 68 | |
| 7 | 2012 | 60 | |
| 8 | 2011 | 58 | |
| 9 | 2014 | 48 | |
| 10 | 2017 | 47 | |
| 11 | 2019 | 40 | |
| 12 | 2012 | 37 | |
| 13 | 2012 | 28 | |
| 14 | 2008 | 23 | |
| 15 | 2023 | 10 | |
| 16 | 2019 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2015 | 4 | |
| 19 | 2012 | 2 | |
| 20 | 2014 | 2 |
About Daniela Fliegner
Daniela Fliegner is a scholar working on Cardiology and Cardiovascular Medicine, Genetics, Molecular Biology, Spectroscopy and Small Animals, having authored 21 papers that have together received 1k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (11 papers), Estrogen and related hormone effects (6 papers), Advanced Proteomics Techniques and Applications (2 papers), Cardiovascular and exercise physiology (1 paper), Cardiovascular Effects of Exercise (1 paper), Microbial Metabolic Engineering and Bioproduction (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (483 citations), Genetics (190 citations), Molecular Biology (258 citations), Complementary and alternative medicine (35 citations) and Cancer Research (48 citations). Daniela Fliegner has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Vera Regitz‐Zagrosek, Georgios Kararigas, Elke Dworatzek, Carola Schubert, Jan-Ακε Gustafsson, Adam Penkalla, Shokoufeh Mahmoodzadeh, Hugo Sanchez‐Ruderisch, Patricia Ruíz and Henning Witt. Their work appears in journals such as Cardiovascular Research, Handbook of experimental pharmacology, PLoS ONE, Journal of Cellular and Molecular Medicine and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.